DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 133 filers reported holding DIPLOMAT PHARMACY INC in Q2 2019. The put-call ratio across all filers is 2.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $213,000 | -23.1% | 53,380 | -0.1% | 0.00% | 0.0% |
Q3 2019 | $277,000 | -1.4% | 53,430 | +1.9% | 0.00% | 0.0% |
Q2 2019 | $281,000 | -12.7% | 52,411 | -6.7% | 0.00% | -33.3% |
Q1 2019 | $322,000 | -55.6% | 56,168 | +2.9% | 0.00% | -50.0% |
Q4 2018 | $725,000 | -36.6% | 54,559 | -0.4% | 0.01% | -33.3% |
Q3 2018 | $1,144,000 | -13.6% | 54,799 | +7.1% | 0.01% | 0.0% |
Q2 2018 | $1,324,000 | +18.5% | 51,147 | -3.6% | 0.01% | +12.5% |
Q1 2018 | $1,117,000 | -16.6% | 53,077 | +2.5% | 0.01% | -11.1% |
Q4 2017 | $1,340,000 | +28.0% | 51,796 | +2.6% | 0.01% | +12.5% |
Q3 2017 | $1,047,000 | +47.3% | 50,475 | +9.8% | 0.01% | +60.0% |
Q2 2017 | $711,000 | -4.2% | 45,951 | -4.8% | 0.01% | -16.7% |
Q1 2017 | $742,000 | +14.3% | 48,247 | +4.6% | 0.01% | +20.0% |
Q4 2016 | $649,000 | -48.4% | 46,130 | +2.9% | 0.01% | -54.5% |
Q3 2016 | $1,257,000 | -9.2% | 44,837 | +19.0% | 0.01% | -8.3% |
Q2 2016 | $1,385,000 | – | 37,666 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sandhill Capital Partners LLC | 369,015 | $12,916,000 | 4.04% |
OBERWEIS ASSET MANAGEMENT INC/ | 237,515 | $8,313,000 | 2.47% |
WEATHERBIE CAPITAL, LLC | 259,175 | $9,071,000 | 1.29% |
Summit Creek Advisors LLC | 216,385 | $7,573,000 | 1.29% |
Cambridge Investment Research Advisors, Inc. | 1,700,106 | $59,504,000 | 1.26% |
Hood River Capital Management LLC | 265,388 | $9,289,000 | 1.24% |
Sivik Global Healthcare LLC | 65,000 | $2,275,000 | 1.13% |
Friedberg Investment Management | 63,430 | $2,220,000 | 1.05% |
Granite Investment Partners, LLC | 342,839 | $12,000,000 | 0.95% |
Tributary Capital Management, LLC | 176,289 | $6,170,000 | 0.90% |